Longeveron (LGVN) Invested Capital (2020 - 2026)

Longeveron (LGVN) recorded quarterly Invested Capital of $16.0 million in Q1 2026, up 182.41% quarter-over-quarter from $5.7 million in Q4 2025, and down 6.59% on a YoY basis from $17.2 million in Q1 2025.

Longeveron (LGVN) Invested Capital (2020 - 2026) Analysis & Trends

Longeveron's Invested Capital history runs 7 years deep, the most recent figure standing at $16.0 million for Q1 2026.

  • In Q1 2026, Invested Capital fell 6.59% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $16.0 million (down 6.59% YoY), while the FY2025 annual figure was $5.7 million, down 74.07% from the prior year.
  • Invested Capital was $16.0 million for Q1 2026 at Longeveron, up from $5.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $34.3 million in Q1 2022 to a low of $3.0 million in Q1 2024.
  • Historically, Invested Capital has averaged $16.6 million across 5 years, with a median of $16.0 million in 2026.
  • The sharpest annual moves came in 2024 and 2025: Invested Capital tumbled 83.3% in 2024, then surged 464.22% in 2025.
  • A 5-year view of Invested Capital shows it stood at $22.5 million in 2022, then plunged by 70.1% to $6.7 million in 2023, then soared by 224.68% to $21.9 million in 2024, then plunged by 74.07% to $5.7 million in 2025, then soared by 182.41% to $16.0 million in 2026.
  • The last three Invested Capital figures came in at $16.0 million (Q1 2026), $5.7 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 16.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.03 Mn
Dec 31, 2025 5.68 Mn
Sep 30, 2025 9.97 Mn
Jun 30, 2025 12.66 Mn
Mar 31, 2025 17.16 Mn
Dec 31, 2024 21.89 Mn
Sep 30, 2024 25.63 Mn
Jun 30, 2024 14.91 Mn
Mar 31, 2024 3.04 Mn
Dec 31, 2023 6.74 Mn
Sep 30, 2023 7.22 Mn
Jun 30, 2023 11.84 Mn
Mar 31, 2023 18.21 Mn
Dec 31, 2022 22.54 Mn
Sep 30, 2022 24.62 Mn
Jun 30, 2022 29.38 Mn
Mar 31, 2022 34.31 Mn
Dec 31, 2021 40.06 Mn
Dec 31, 2020 1.96 Mn